Presenters to the Beacon Angels Meeting on April 12, 2016 included:
- Or-Genix Therapeutics, which is developing and out-licensing proprietary science based topical products to help prevent and treat hormonally aging skin and hair in women aged 40+; and
- Launchpad Medical, which is developing and commercializing Tetranite,™ a proprietary adhesive that supports and integrates with the body’s self repair mechanisms to help regrow bone and permanently stabilize metal hardware—initially for dental implants.
Both companies were accepted for Due Diligence.
Members delivered due diligence reports on Dookans, Gadfly Legal and IQuartic.